Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Cancer
|
July 4, 2014
Exercise-induced lung cancer regression: mechanistic findings from a mouse model
Kristin A Higgins, Dongkyoo Park, Gee Young Lee, et al.
The Journal of Biological Chemistry
|
January 30, 2007
Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex
Yongzhong Hou, Fengqin Gao, Qinhong Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
February 1, 2019
Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
Chen Guo, Guan Li, Jianing Hou, et al.
Frontiers in Oncology
|
February 21, 2022
Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages
Zhuofei Li, Xingming Deng, Jun Luo, et al.
Experimental Hematology
|
November 21, 2007
Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells
Yan-Yi Wang, Xingming Deng, Lijun Xu, et al.
Neoplasia (New York, N.Y.)
|
October 8, 2010
Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E
Yikun Li, Ping Yue, Xingming Deng, et al.
The Journal of Biological Chemistry
|
March 26, 2010
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation
Chunyang Li, Shuzhen Chen, Ping Yue, et al.
The Journal of Biological Chemistry
|
June 28, 2020
Correction: Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IκBα degradation
Chunyang Li, Shuzhen Chen, Ping Yue, et al.
Neoplasia (New York, N.Y.)
|
July 19, 2024
Corrigendum to "Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E" [Neoplasia, volume 12, issue 10 (2010):848 -855]
Yikun Li, Ping Yue, Xingming Deng, et al.
International Journal of Pharmaceutics
|
January 26, 2012
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
Jinghua Duan, Heidi M Mansour, Yangde Zhang, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Cancer
|
July 4, 2014
Exercise-induced lung cancer regression: mechanistic findings from a mouse model
Kristin A Higgins, Dongkyoo Park, Gee Young Lee, et al.
The Journal of Biological Chemistry
|
January 30, 2007
Bcl2 impedes DNA mismatch repair by directly regulating the hMSH2-hMSH6 heterodimeric complex
Yongzhong Hou, Fengqin Gao, Qinhong Wang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
February 1, 2019
Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
Chen Guo, Guan Li, Jianing Hou, et al.
Frontiers in Oncology
|
February 21, 2022
Metabolomic Comparison of Patients With Colorectal Cancer at Different Anticancer Treatment Stages
Zhuofei Li, Xingming Deng, Jun Luo, et al.
Experimental Hematology
|
November 21, 2007
Bcl2 enhances induced hematopoietic differentiation of murine embryonic stem cells
Yan-Yi Wang, Xingming Deng, Lijun Xu, et al.
Neoplasia (New York, N.Y.)
|
October 8, 2010
Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E
Yikun Li, Ping Yue, Xingming Deng, et al.
The Journal of Biological Chemistry
|
March 26, 2010
Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation
Chunyang Li, Shuzhen Chen, Ping Yue, et al.
The Journal of Biological Chemistry
|
June 28, 2020
Correction: Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IκBα degradation
Chunyang Li, Shuzhen Chen, Ping Yue, et al.
Neoplasia (New York, N.Y.)
|
July 19, 2024
Corrigendum to "Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E" [Neoplasia, volume 12, issue 10 (2010):848 -855]
Yikun Li, Ping Yue, Xingming Deng, et al.
International Journal of Pharmaceutics
|
January 26, 2012
Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles
Jinghua Duan, Heidi M Mansour, Yangde Zhang, et al.
Page
of 10